News
Hikma launches Labetalol Hydrochloride Injection, USP in prefilled syringe
News
Hikma launches Icosapent Ethyl Capsules, 0.5g, in the US
News
Hikma launches Cefazolin for Injection, USP, in the US
Watch Said Darwazah, Executive Chairman and Chief Executive Officer discuss our 2022 financial results
Notice of Annual General Meeting
Friday 28 April 2023, 11.00 AM GMT, Sofitel London St James, 6 Waterloo Place, London SW1Y 4AN
#OwnYourCareer@Hikma
Meet Kimberly Lembo, Associate Director, Contract Lifecycle Management and Systems, US and discover why she loves working at Hikma!
#OwnYourCareer@Hikma
Meet Carl Mullner, Manager, Offer Development, US and discover why he loves working at Hikma!
Latest blogpost
Read the latest blog post by Lana Ghanem, Managing Director, Hikma Ventures and Vice President, Digital Health Investments & Partnerships - Investing in the disruptive future of the pharmaceutical industry.
Latest blogpost
Read the latest blog post by Riad Mishlawi, President, Hikma Injectables on Hikma’s world class Injectables capabilities - bringing access to critical medicines.
Careers
Join us in helping to put better health within reach for millions of people
Find out more
Our 2021 Sustainability Report
Find out more
Our 2022 Annual Report